Zevra Therapeutics (ZVRA) Cash & Equivalents (QoQ) (2014 - 2026)
Zevra Therapeutics (ZVRA) Cash & Equivalents (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Zevra Therapeutics | 570.04 Mn | 369.43 Mn | 34.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53.18% |
| Dec 31, 2025 | 14.63% |
| Sep 30, 2025 | 14.10% |
| Jun 30, 2025 | 27.78% |
| Mar 31, 2025 | 10.52% |
| Dec 31, 2024 | -37.48% |
| Sep 30, 2024 | 37.64% |
| Jun 30, 2024 | -8.38% |
| Mar 31, 2024 | -0.46% |
| Dec 31, 2023 | -0.51% |
| Mar 31, 2023 | -38.62% |
| Dec 31, 2022 | -6.56% |
| Sep 30, 2022 | -8.75% |
| Dec 31, 2021 | -14.57% |
| Sep 30, 2021 | -0.60% |
| Jun 30, 2021 | 74.26% |
| Mar 31, 2021 | 1,701.97% |
| Dec 31, 2020 | -20.01% |
| Sep 30, 2020 | -17.30% |
| Jun 30, 2020 | 170.33% |